GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (LTS:0A7L) » Definitions » EV-to-FCF

iRhythm Technologies (LTS:0A7L) EV-to-FCF : -26.64 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is iRhythm Technologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, iRhythm Technologies's Enterprise Value is $3,014.0 Mil. iRhythm Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-113.2 Mil. Therefore, iRhythm Technologies's EV-to-FCF for today is -26.64.

The historical rank and industry rank for iRhythm Technologies's EV-to-FCF or its related term are showing as below:

LTS:0A7L' s EV-to-FCF Range Over the Past 10 Years
Min: -260.06   Med: -56.7   Max: -26.88
Current: -26.94

During the past 10 years, the highest EV-to-FCF of iRhythm Technologies was -26.88. The lowest was -260.06. And the median was -56.70.

LTS:0A7L's EV-to-FCF is ranked worse than
100% of 361 companies
in the Medical Devices & Instruments industry
Industry Median: 28.3 vs LTS:0A7L: -26.94

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), iRhythm Technologies's stock price is $91.47. iRhythm Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-4.230. Therefore, iRhythm Technologies's PE Ratio for today is At Loss.


iRhythm Technologies EV-to-FCF Historical Data

The historical data trend for iRhythm Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies EV-to-FCF Chart

iRhythm Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.65 -244.27 -50.89 -51.97 -36.56

iRhythm Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -78.49 -62.62 -51.50 -36.56 -33.36

Competitive Comparison of iRhythm Technologies's EV-to-FCF

For the Medical Devices subindustry, iRhythm Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRhythm Technologies's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where iRhythm Technologies's EV-to-FCF falls into.



iRhythm Technologies EV-to-FCF Calculation

iRhythm Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3014.010/-113.154
=-26.64

iRhythm Technologies's current Enterprise Value is $3,014.0 Mil.
iRhythm Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-113.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iRhythm Technologies  (LTS:0A7L) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

iRhythm Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=91.47/-4.230
=At Loss

iRhythm Technologies's share price for today is $91.47.
iRhythm Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.230.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


iRhythm Technologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


iRhythm Technologies (LTS:0A7L) Business Description

Traded in Other Exchanges
Address
699 8th Street, Suite 600, San Francisco, CA, USA, 94103
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

iRhythm Technologies (LTS:0A7L) Headlines

No Headlines